Author

Matthew E. Crawford

Pfizer (United States)

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Genomics· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:differential expression· 1 Research Focus:GWAS / association mapping· 1 Organism:human· 1 Approach:statistical model· 1

Frequent Co-Authors

Ayellet V. SegrèiD· 1 shared François AguetiD· 1 shared Hualin Simon XiiD· 1 shared Jie QuaniD· 1 shared John AlleniD· 1 shared Kristin ArdlieiD· 1 shared Reza Sodaei· 1 shared Robert Yang· 1 shared

Activity by Year

2018-2018 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperGenomics

Ayellet V. SegrèORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

A systematic survey of human tissue-specific gene expression and splicing reveals new opportunities for therapeutic target identification and evaluation

Robert Yang, Jie Quan, Reza Sodaei, François Aguet, Ayellet V. Segrè, John Allen, Thomas A. Lanz, Veronica Reinhart, Matthew E. Crawford, Samuel A. Hasson, Kristin Ardlie, Roderic Guigó, Hualin Simon Xi

The paper analyzes tissue-specific gene expression and splicing across 8527 RNA-seq samples to identify therapeutic targets and prioritize disease-associated genes.

bioRxiv · Apr 30, 2018 · PreprintGenomics